Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology
Enzymit has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
Enzymit's investors include Khosla Ventures, Israel Innovation Authority, MassChallenge, First Star Ventures, Grove Ventures.
Enzymit is headquartered in Ness Ziona, Israel.
Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology
Enzymit is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enzymit — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/enzymit. Accessed July 19, 2026.
VCBacked. (2024). Enzymit — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/enzymit
{{cite web |title=Enzymit — Funding & Investors |url=https://www.vcbacked.co/company/enzymit |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated